Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trials

M Bhutani; Q Zhang; R Friend; PM Voorhees; LJ Druhan; B Barlogie; Pieter Sonneveld; GJ Morgan; JT Symanowski; BR Avalos; EA Copelan; S Z Usmani

doi:10.1016/S2352-3026(17)30143-6

Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trials

M Bhutani, Q Zhang, R Friend, PM Voorhees, LJ Druhan, B Barlogie, Pieter Sonneveld, GJ Morgan, JT Symanowski, BR Avalos, EA Copelan, S Z Usmani

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

16 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	E443-E451
Journal	Lancet Haematology
Volume	4
Issue number	9
DOIs	https://doi.org/10.1016/S2352-3026(17)30143-6
Publication status	Published - 2017

Access to Document

10.1016/S2352-3026(17)30143-6

http://hdl.handle.net/1765/101723

Cite this

Bhutani, M., Zhang, Q., Friend, R., Voorhees, PM., Druhan, LJ., Barlogie, B., Sonneveld, P., Morgan, GJ., Symanowski, JT., Avalos, BR., Copelan, EA., & Usmani, S. Z. (2017). Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trials. Lancet Haematology, 4(9), E443-E451. https://doi.org/10.1016/S2352-3026(17)30143-6

Bhutani, M ; Zhang, Q ; Friend, R ; Voorhees, PM ; Druhan, LJ ; Barlogie, B ; Sonneveld, Pieter ; Morgan, GJ ; Symanowski, JT ; Avalos, BR ; Copelan, EA ; Usmani, S Z. / Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trials. In: Lancet Haematology. 2017 ; Vol. 4, No. 9. pp. E443-E451.

@article{6349431b39e94636baac9fd01edd4f57,

title = "Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trials",

author = "M Bhutani and Q Zhang and R Friend and PM Voorhees and LJ Druhan and B Barlogie and Pieter Sonneveld and GJ Morgan and JT Symanowski and BR Avalos and EA Copelan and Usmani, {S Z}",

year = "2017",

doi = "10.1016/S2352-3026(17)30143-6",

language = "Undefined/Unknown",

volume = "4",

pages = "E443--E451",

journal = "The Lancet Haematology",

issn = "2352-3026",

publisher = "Lancet Publishing Group",

number = "9",

}

Bhutani, M, Zhang, Q, Friend, R, Voorhees, PM, Druhan, LJ, Barlogie, B, Sonneveld, P, Morgan, GJ, Symanowski, JT, Avalos, BR, Copelan, EA & Usmani, SZ 2017, 'Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trials', Lancet Haematology, vol. 4, no. 9, pp. E443-E451. https://doi.org/10.1016/S2352-3026(17)30143-6

Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trials. / Bhutani, M; Zhang, Q; Friend, R; Voorhees, PM; Druhan, LJ; Barlogie, B; Sonneveld, Pieter; Morgan, GJ; Symanowski, JT; Avalos, BR; Copelan, EA; Usmani, S Z.

In: Lancet Haematology, Vol. 4, No. 9, 2017, p. E443-E451.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trials

AU - Bhutani, M

AU - Zhang, Q

AU - Friend, R

AU - Voorhees, PM

AU - Druhan, LJ

AU - Barlogie, B

AU - Sonneveld, Pieter

AU - Morgan, GJ

AU - Symanowski, JT

AU - Avalos, BR

AU - Copelan, EA

AU - Usmani, S Z

PY - 2017

Y1 - 2017

U2 - 10.1016/S2352-3026(17)30143-6

DO - 10.1016/S2352-3026(17)30143-6

M3 - Article

VL - 4

SP - E443-E451

JO - The Lancet Haematology

JF - The Lancet Haematology

SN - 2352-3026

IS - 9

ER -

Bhutani M, Zhang Q, Friend R, Voorhees PM, Druhan LJ, Barlogie B et al. Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trials. Lancet Haematology. 2017;4(9):E443-E451. https://doi.org/10.1016/S2352-3026(17)30143-6